Bizily Scott (CIK 1920738) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy FDMT (814 shares), Buy FDMT (5,752 shares), Sell FDMT (6,566 shares), Buy FDMT (9,810 shares), Sell FDMT (9,810 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Buy | 814 | $3,370 |
| 2026-07-02 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Buy | 5,752 | $37,330 |
| 2026-07-02 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Sell | 6,566 | $91,924 |
| 2026-06-25 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Buy | 9,810 | $40,613 |
| 2026-06-25 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Sell | 9,810 | $117,720 |
| 2025-12-19 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Buy | 1,635 | $6,769 |
| 2025-12-19 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Sell | 1,635 | $17,822 |
| 2025-11-19 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Buy | 1,635 | $6,769 |
| 2025-11-19 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Sell | 1,635 | $17,315 |
| 2025-10-27 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Buy | 1,084 | $7,035 |
| 2025-10-27 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Sell | 2,678 | $32,136 |
| 2025-10-20 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Buy | 1,635 | $6,769 |
| 2025-10-20 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Sell | 1,635 | $16,628 |
| 2025-10-14 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Sell | 2,408 | $24,080 |
| 2025-09-26 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | Sell | 2,407 | $19,256 |
Source: SEC Form 4 filings · as of 2026-07-02